The global market for Liquid Biopsy Diagnostic Tool was valued at US$ 1771 million in the year 2024 and is projected to reach a revised size of US$ 6204 million by 2031, growing at a CAGR of 19.9% during the forecast period.

Liquid Biopsy Diagnostic Tool Market

Liquid Biopsy Diagnostic Tool is a medical device or technology that analyzes various biomarkers present in bodily fluids, such as blood, to detect diseases like cancer or other health conditions. It offers a less invasive alternative to traditional tissue biopsies.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Diagnostic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Diagnostic Tool.

The Liquid Biopsy Diagnostic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liquid Biopsy Diagnostic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liquid Biopsy Diagnostic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Liquid Biopsy Diagnostic Tool Market Report

Report Metric	Details
Report Name	Liquid Biopsy Diagnostic Tool Market
Accounted market size in year	US$ 1771 million
Forecasted market size in 2031	US$ 6204 million
CAGR	19.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Instrument Reagent Others
Segment by Application	Hospital Third-party Testing Agency
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini-Silicon Biosystems, Trovagene, Guardant Health, Mdxhealth, Genomic Health, Raindance Technologies, Thermo Fisher Scientific, Illumina, Amoy Diagnostics, Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Diagnostic Tool company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Liquid Biopsy Diagnostic Tool Market growing?

Ans: The Liquid Biopsy Diagnostic Tool Market witnessing a CAGR of 19.9% during the forecast period 2025-2031.

What is the Liquid Biopsy Diagnostic Tool Market size in 2031?

Ans: The Liquid Biopsy Diagnostic Tool Market size in 2031 will be US$ 6204 million.

Who are the main players in the Liquid Biopsy Diagnostic Tool Market report?

Ans: The main players in the Liquid Biopsy Diagnostic Tool Market are Biocept, Qiagen, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini-Silicon Biosystems, Trovagene, Guardant Health, Mdxhealth, Genomic Health, Raindance Technologies, Thermo Fisher Scientific, Illumina, Amoy Diagnostics, Johnson & Johnson

What are the Application segmentation covered in the Liquid Biopsy Diagnostic Tool Market report?

Ans: The Applications covered in the Liquid Biopsy Diagnostic Tool Market report are Hospital, Third-party Testing Agency

What are the Type segmentation covered in the Liquid Biopsy Diagnostic Tool Market report?

Ans: The Types covered in the Liquid Biopsy Diagnostic Tool Market report are Instrument, Reagent, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Instrument

1.2.3 Reagent

1.2.4 Others

1.3 Market by Application

1.3.1 Global Liquid Biopsy Diagnostic Tool Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Third-party Testing Agency

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Liquid Biopsy Diagnostic Tool Market Perspective (2020-2031)

2.2 Global Liquid Biopsy Diagnostic Tool Growth Trends by Region

2.2.1 Global Liquid Biopsy Diagnostic Tool Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Liquid Biopsy Diagnostic Tool Historic Market Size by Region (2020-2025)

2.2.3 Liquid Biopsy Diagnostic Tool Forecasted Market Size by Region (2026-2031)

2.3 Liquid Biopsy Diagnostic Tool Market Dynamics

2.3.1 Liquid Biopsy Diagnostic Tool Industry Trends

2.3.2 Liquid Biopsy Diagnostic Tool Market Drivers

2.3.3 Liquid Biopsy Diagnostic Tool Market Challenges

2.3.4 Liquid Biopsy Diagnostic Tool Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue

3.1.1 Global Top Liquid Biopsy Diagnostic Tool Players by Revenue (2020-2025)

3.1.2 Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Players (2020-2025)

3.2 Global Liquid Biopsy Diagnostic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Liquid Biopsy Diagnostic Tool Revenue

3.4 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio

3.4.1 Global Liquid Biopsy Diagnostic Tool Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Diagnostic Tool Revenue in 2024

3.5 Global Key Players of Liquid Biopsy Diagnostic Tool Head office and Area Served

3.6 Global Key Players of Liquid Biopsy Diagnostic Tool, Product and Application

3.7 Global Key Players of Liquid Biopsy Diagnostic Tool, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Liquid Biopsy Diagnostic Tool Breakdown Data by Type

4.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Type (2020-2025)

4.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Type (2026-2031)

5 Liquid Biopsy Diagnostic Tool Breakdown Data by Application

5.1 Global Liquid Biopsy Diagnostic Tool Historic Market Size by Application (2020-2025)

5.2 Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Liquid Biopsy Diagnostic Tool Market Size (2020-2031)

6.2 North America Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025)

6.4 North America Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Liquid Biopsy Diagnostic Tool Market Size (2020-2031)

7.2 Europe Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025)

7.4 Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size (2020-2031)

8.2 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2020-2025)

8.4 Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Liquid Biopsy Diagnostic Tool Market Size (2020-2031)

9.2 Latin America Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025)

9.4 Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size (2020-2031)

10.2 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025)

10.4 Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biocept

11.1.1 Biocept Company Details

11.1.2 Biocept Business Overview

11.1.3 Biocept Liquid Biopsy Diagnostic Tool Introduction

11.1.4 Biocept Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.1.5 Biocept Recent Development

11.2 Qiagen

11.2.1 Qiagen Company Details

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Liquid Biopsy Diagnostic Tool Introduction

11.2.4 Qiagen Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.2.5 Qiagen Recent Development

11.3 Roche Diagnostics

11.3.1 Roche Diagnostics Company Details

11.3.2 Roche Diagnostics Business Overview

11.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Introduction

11.3.4 Roche Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.3.5 Roche Diagnostics Recent Development

11.4 Bio-Rad Laboratories

11.4.1 Bio-Rad Laboratories Company Details

11.4.2 Bio-Rad Laboratories Business Overview

11.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Introduction

11.4.4 Bio-Rad Laboratories Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.4.5 Bio-Rad Laboratories Recent Development

11.5 Myriad Genetics

11.5.1 Myriad Genetics Company Details

11.5.2 Myriad Genetics Business Overview

11.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Introduction

11.5.4 Myriad Genetics Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.5.5 Myriad Genetics Recent Development

11.6 Menarini-Silicon Biosystems

11.6.1 Menarini-Silicon Biosystems Company Details

11.6.2 Menarini-Silicon Biosystems Business Overview

11.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Introduction

11.6.4 Menarini-Silicon Biosystems Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.6.5 Menarini-Silicon Biosystems Recent Development

11.7 Trovagene

11.7.1 Trovagene Company Details

11.7.2 Trovagene Business Overview

11.7.3 Trovagene Liquid Biopsy Diagnostic Tool Introduction

11.7.4 Trovagene Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.7.5 Trovagene Recent Development

11.8 Guardant Health

11.8.1 Guardant Health Company Details

11.8.2 Guardant Health Business Overview

11.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Introduction

11.8.4 Guardant Health Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.8.5 Guardant Health Recent Development

11.9 Mdxhealth

11.9.1 Mdxhealth Company Details

11.9.2 Mdxhealth Business Overview

11.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Introduction

11.9.4 Mdxhealth Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.9.5 Mdxhealth Recent Development

11.10 Genomic Health

11.10.1 Genomic Health Company Details

11.10.2 Genomic Health Business Overview

11.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Introduction

11.10.4 Genomic Health Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.10.5 Genomic Health Recent Development

11.11 Raindance Technologies

11.11.1 Raindance Technologies Company Details

11.11.2 Raindance Technologies Business Overview

11.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Introduction

11.11.4 Raindance Technologies Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.11.5 Raindance Technologies Recent Development

11.12 Thermo Fisher Scientific

11.12.1 Thermo Fisher Scientific Company Details

11.12.2 Thermo Fisher Scientific Business Overview

11.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Introduction

11.12.4 Thermo Fisher Scientific Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.12.5 Thermo Fisher Scientific Recent Development

11.13 Illumina

11.13.1 Illumina Company Details

11.13.2 Illumina Business Overview

11.13.3 Illumina Liquid Biopsy Diagnostic Tool Introduction

11.13.4 Illumina Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.13.5 Illumina Recent Development

11.14 Amoy Diagnostics

11.14.1 Amoy Diagnostics Company Details

11.14.2 Amoy Diagnostics Business Overview

11.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Introduction

11.14.4 Amoy Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.14.5 Amoy Diagnostics Recent Development

11.15 Johnson & Johnson

11.15.1 Johnson & Johnson Company Details

11.15.2 Johnson & Johnson Business Overview

11.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Introduction

11.15.4 Johnson & Johnson Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025)

11.15.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Menarini Silicon Biosystems

RainDance Technologies

Thermo Fisher Scientific

Illumina Inc

Amoy Diagnostics

Johnson & Johnson

List of Tables

Table 1. Global Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Instrument

Table 3. Key Players of Reagent

Table 4. Key Players of Others

Table 5. Global Liquid Biopsy Diagnostic Tool Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Liquid Biopsy Diagnostic Tool Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Liquid Biopsy Diagnostic Tool Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Liquid Biopsy Diagnostic Tool Market Share by Region (2020-2025)

Table 9. Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Liquid Biopsy Diagnostic Tool Market Share by Region (2026-2031)

Table 11. Liquid Biopsy Diagnostic Tool Market Trends

Table 12. Liquid Biopsy Diagnostic Tool Market Drivers

Table 13. Liquid Biopsy Diagnostic Tool Market Challenges

Table 14. Liquid Biopsy Diagnostic Tool Market Restraints

Table 15. Global Liquid Biopsy Diagnostic Tool Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Liquid Biopsy Diagnostic Tool Market Share by Players (2020-2025)

Table 17. Global Top Liquid Biopsy Diagnostic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy Diagnostic Tool as of 2024)

Table 18. Ranking of Global Top Liquid Biopsy Diagnostic Tool Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Liquid Biopsy Diagnostic Tool Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Liquid Biopsy Diagnostic Tool, Headquarters and Area Served

Table 21. Global Key Players of Liquid Biopsy Diagnostic Tool, Product and Application

Table 22. Global Key Players of Liquid Biopsy Diagnostic Tool, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Liquid Biopsy Diagnostic Tool Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Type (2020-2025)

Table 26. Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Type (2026-2031)

Table 28. Global Liquid Biopsy Diagnostic Tool Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Application (2020-2025)

Table 30. Global Liquid Biopsy Diagnostic Tool Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Liquid Biopsy Diagnostic Tool Revenue Market Share by Application (2026-2031)

Table 32. North America Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 47. Biocept Company Details

Table 48. Biocept Business Overview

Table 49. Biocept Liquid Biopsy Diagnostic Tool Product

Table 50. Biocept Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 51. Biocept Recent Development

Table 52. Qiagen Company Details

Table 53. Qiagen Business Overview

Table 54. Qiagen Liquid Biopsy Diagnostic Tool Product

Table 55. Qiagen Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 56. Qiagen Recent Development

Table 57. Roche Diagnostics Company Details

Table 58. Roche Diagnostics Business Overview

Table 59. Roche Diagnostics Liquid Biopsy Diagnostic Tool Product

Table 60. Roche Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 61. Roche Diagnostics Recent Development

Table 62. Bio-Rad Laboratories Company Details

Table 63. Bio-Rad Laboratories Business Overview

Table 64. Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Product

Table 65. Bio-Rad Laboratories Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 66. Bio-Rad Laboratories Recent Development

Table 67. Myriad Genetics Company Details

Table 68. Myriad Genetics Business Overview

Table 69. Myriad Genetics Liquid Biopsy Diagnostic Tool Product

Table 70. Myriad Genetics Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 71. Myriad Genetics Recent Development

Table 72. Menarini-Silicon Biosystems Company Details

Table 73. Menarini-Silicon Biosystems Business Overview

Table 74. Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Product

Table 75. Menarini-Silicon Biosystems Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 76. Menarini-Silicon Biosystems Recent Development

Table 77. Trovagene Company Details

Table 78. Trovagene Business Overview

Table 79. Trovagene Liquid Biopsy Diagnostic Tool Product

Table 80. Trovagene Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 81. Trovagene Recent Development

Table 82. Guardant Health Company Details

Table 83. Guardant Health Business Overview

Table 84. Guardant Health Liquid Biopsy Diagnostic Tool Product

Table 85. Guardant Health Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 86. Guardant Health Recent Development

Table 87. Mdxhealth Company Details

Table 88. Mdxhealth Business Overview

Table 89. Mdxhealth Liquid Biopsy Diagnostic Tool Product

Table 90. Mdxhealth Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 91. Mdxhealth Recent Development

Table 92. Genomic Health Company Details

Table 93. Genomic Health Business Overview

Table 94. Genomic Health Liquid Biopsy Diagnostic Tool Product

Table 95. Genomic Health Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 96. Genomic Health Recent Development

Table 97. Raindance Technologies Company Details

Table 98. Raindance Technologies Business Overview

Table 99. Raindance Technologies Liquid Biopsy Diagnostic Tool Product

Table 100. Raindance Technologies Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 101. Raindance Technologies Recent Development

Table 102. Thermo Fisher Scientific Company Details

Table 103. Thermo Fisher Scientific Business Overview

Table 104. Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Product

Table 105. Thermo Fisher Scientific Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 106. Thermo Fisher Scientific Recent Development

Table 107. Illumina Company Details

Table 108. Illumina Business Overview

Table 109. Illumina Liquid Biopsy Diagnostic Tool Product

Table 110. Illumina Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 111. Illumina Recent Development

Table 112. Amoy Diagnostics Company Details

Table 113. Amoy Diagnostics Business Overview

Table 114. Amoy Diagnostics Liquid Biopsy Diagnostic Tool Product

Table 115. Amoy Diagnostics Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 116. Amoy Diagnostics Recent Development

Table 117. Johnson & Johnson Company Details

Table 118. Johnson & Johnson Business Overview

Table 119. Johnson & Johnson Liquid Biopsy Diagnostic Tool Product

Table 120. Johnson & Johnson Revenue in Liquid Biopsy Diagnostic Tool Business (2020-2025) & (US$ Million)

Table 121. Johnson & Johnson Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Liquid Biopsy Diagnostic Tool Picture

Figure 2. Global Liquid Biopsy Diagnostic Tool Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Liquid Biopsy Diagnostic Tool Market Share by Type: 2024 VS 2031

Figure 4. Instrument Features

Figure 5. Reagent Features

Figure 6. Others Features

Figure 7. Global Liquid Biopsy Diagnostic Tool Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Liquid Biopsy Diagnostic Tool Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Third-party Testing Agency Case Studies

Figure 11. Liquid Biopsy Diagnostic Tool Report Years Considered

Figure 12. Global Liquid Biopsy Diagnostic Tool Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Liquid Biopsy Diagnostic Tool Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Liquid Biopsy Diagnostic Tool Market Share by Region: 2024 VS 2031

Figure 15. Global Liquid Biopsy Diagnostic Tool Market Share by Players in 2024

Figure 16. Global Top Liquid Biopsy Diagnostic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Biopsy Diagnostic Tool as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Liquid Biopsy Diagnostic Tool Revenue in 2024

Figure 18. North America Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Liquid Biopsy Diagnostic Tool Market Share by Country (2020-2031)

Figure 20. United States Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Liquid Biopsy Diagnostic Tool Market Share by Country (2020-2031)

Figure 24. Germany Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Liquid Biopsy Diagnostic Tool Market Share by Region (2020-2031)

Figure 32. China Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Liquid Biopsy Diagnostic Tool Market Share by Country (2020-2031)

Figure 40. Mexico Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Liquid Biopsy Diagnostic Tool Market Share by Country (2020-2031)

Figure 44. Turkey Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Liquid Biopsy Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Biocept Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 48. Qiagen Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 49. Roche Diagnostics Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 51. Myriad Genetics Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 52. Menarini-Silicon Biosystems Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 53. Trovagene Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 54. Guardant Health Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 55. Mdxhealth Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 56. Genomic Health Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 57. Raindance Technologies Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 59. Illumina Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 60. Amoy Diagnostics Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 61. Johnson & Johnson Revenue Growth Rate in Liquid Biopsy Diagnostic Tool Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global 3D 4K Video Endoscopy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19J19091

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Disposable Fully Automatic Puncture Biopsy Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V19153

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Knee Joint Replacement Implants Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36E18899

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global EMG Test System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37U11188

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions